PHANZ MEDIA RELEASE APRIL 2021

22 Apr 2021 1:50 PM | Anonymous

Public Health Association supports Smokefree Aotearoa 2025 announcements by Associate Minister of Health, Dr Ayesha Verrall

MEDIA RELEASE 19 April 2021

The Public Health Association of New Zealand applauds the proposed raft of changes to tobacco smoking controls by Associate Minister of Health, Dr. Ayesha Verrall. The Smokefree Aotearoa 2025 Action Plan proposals, were released as part of a discussion document last Thursday 15th April, 2021. The proposals include sweeping cuts to tobacco retailers, the banning of tobacco sales to new smokers, limiting tobacco sales to specific R18 stores or pharmacies, the reduction of nicotine in products and a prohibition on filters in cigarettes. These are excellent proposals and are strongly supported by the PHANZ. “Around 4,500 people a year die because of tobaccoin New Zealand. This is carnage on an industrial scale, and affects Maori and Pasifika peoples disproportionately. We need to do everything that we can to protect our whanau and our whakapapa,” said Grant Berghan, Chief Executive Officer of the PHANZ.

Read our full media release here

Public Health Association Logo


Get curious

Get engaged

Get involved


Upcoming events

The PHA – a strong and informed collective voice for a healthy and well New Zealand.

Privacy | Contact

Copyright © Public Health Association of New Zealand 2016

Log in

Letter to the Listener 28 July 2017 in response to Fever Pitch (Listener 21 July 2017)

Catherine Woulfe’s thorough investigation of rheumatic fever brings to the surface a range of important questions not only about this cruel disease, but also wider issues about health policy. The Government’s bold initiative to reduce the incidence of rheumatic fever as one of its 'Better Public Service' targets in 2012 certainly raised awareness of rheumatic fever for the general public as well as communities and families directly affected. But even when medical science and the public have a clearer understanding of the immediate causes of rheumatic fever, interventions like the $65m ‘sore throats matter’ still won’t stop the epidemic. 

Ramona Tiatia’s blunt description of the experience of affected families not only painted a picture of the impact on affected families and communities, it also highlighted the invidious choices our health funders face.  How much should we prioritise health spending between response to the urgent need of young people whose lives and potential can be devastated by the disease versus the expense of addressing the economic and social factors that underlie the reasons we have this epidemic at all?   

As several of the clinicians interviewed pointed out, it’s only when the poverty and over-crowded housing issues are addressed that we will make a real difference.

Rheumatic fever illustrates the contradictions in our health system identified in the recent American Commonwealth Fund report. Of the 11 countries the Fund monitors, the work our health professionals do is ranked among the highest. But our overall performance as a health system falls to the middle ranking because of our poor performance on access and equity. The Fund also notes that our per capita expenditure is among the cheapest. 

Failure to invest in real prevention - that is, poverty, housing, good nutrition etc. - will continue to drive conditions like rheumatic fever, whether the immediate cause is strep throat or skin sores, until we invest upstream.

Why not spend more on these conditions - the economic and social determinants of health? 

We all pay in the long run - the young people whose misery we tolerate and whose potential remains unfulfilled, the families whose sacrifices are unrewarded, and the taxpayer who picks up the tab.

Ngā mihi,
Warren Lindberg

CE Public Health Association of New Zealand

                                            

Powered by Wild Apricot Membership Software